TGF-β1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells

Virus Research

Volumn 132, Issue 1-2, 2008, Pages 253-256

  Donalisio, Manuela ^a   Cornaglia, Maura ^a   Landolfo, Santo ^a   Lembo, David ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cervical carcinoma cells; Human papillomavirus; IL 4; Long control region; Senescence; TGF 1

Indexed keywords

INTERLEUKIN 4; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; CARCINOMA CELL; CELL AGING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; NONHUMAN; ONCOGENE; PERSISTENT INFECTION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS INHIBITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

CELL AGING; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTERLEUKIN-4; ONCOGENE PROTEINS, VIRAL; PHENOTYPE; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 39149088632     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.12.003     Document Type: Article

References (22)

1. Baldwin A., Pirisi L., and Creek K.E. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression. J. Virol. 78 (2004) 3953-3964
2. Bosch F.X., and de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J. Natl. Cancer Inst. Monogr. 31 (2003) 3-13 (Chapter 1)
3. Braun L., Durst M., Mikumo R., and Gruppuso P. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1. Cancer Res. 50 (1990) 7324-7332
4. DeFilippis R.A., Goodwin E.C., Wu L., and DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 77 (2003) 1551-1563
5. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., and Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9363-9367
6. Goodwin E.C., and DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 12513-12518
7. Goodwin E.C., Yang E., Lee C.J., Lee H.W., DiMaio D., and Hwang E.S. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10978-10983
8. Hasskarl J., Whitaker N., Ullmann A., Durst M., and Hoppe-Seyler F. Differential cell cycle response of nontumorigenic and tumorigenic human papillomavirus-positive keratinocytes towards transforming growth factor-beta1. J. Mol. Med. 78 (2000) 94-101
9. Howley P.M., and Lowy D.R. Papillomaviruses and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott-Raven, Philadelphia 2197-2229
10. Katakura Y., Nakata E., Miura T., and Shirahata S. Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem. Biophys. Res. Commun. 255 (1999) 110-115
11. Lembo D., Donalisio M., Cornaglia M., Azzimonti B., Demurtas A., and Landolfo S. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage. Virus Res. 122 (2006) 189-193
12. Lembo D., Donalisio M., De Andrea M., Cornaglia M., Scutera S., Musso T., and Landolfo S. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity. FASEB J. 20 (2006) 148-150
13. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68 (2004) 362-372
14. Lowy D.R., and Howley P.M. Papillomaviruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott-Raven, Philadelphia 2231-2264
15. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., and Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78 (2004) 11451-11460
16. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., and Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17 (1999) 701-738
17. Pasche B. Role of transforming growth factor beta in cancer. J. Cell. Physiol. 186 (2001) 153-168
18. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Hederwijin P., Desmyter J., and De Clerq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20 (1988) 309-321
19. Wells S.I., Francis D.A., Karpova A.Y., Dowhanick J.J., Benson J.D., and Howley P.M. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J. 19 (2000) 5762-5771
20. Woodworth C.D., Notario V., and DiPaolo J.A. Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J. Virol. 64 (1990) 4767-4775
21. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. Monogr. 92 (2000) 690-698
22. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer. 2 (2002) 342-350